CAD and cancer: Cancer lesions detected by in vivo measurements (n = 14) exhibited higher ex vivo CPS (median 61, IQR 41–178 vs. median 3, IQR 2–4; p = 0.001; Table S2) and higher CPS ratios (median 14.5, IQR 9.5–31.4 vs. median 0.8, IQR 0.5–1.1; p = 0.001); Table S2) compared to in vivo undetected cancer lesions.